Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Journal of Research in Pharmacy and Pharmaceutical Sciences
Nabila Bintan Ramadhani
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Other

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
A PHARMACOEPIDEMIOLOGY LITERATURE REVIEW OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): ANALYSIS OF RISK FACTORS, COMORBIDITIES, AND THERAPEUTIC PATTERNS Nafeeza Shaqueenami Nasution; Bawana Kheyza Dg Situru; Nisyah Mora Lestari; Nabila Bintan Ramadhani; Talitha Nur Dzakirah; Wafa Nasution
Journal of Research in Pharmacy and Pharmaceutical Sciences Vol 5 No 1 (2026): Vol.5 No.1 JUNE (2026)
Publisher : Pharmacy Program, Faculty of Medicine, UPN Veteran Jakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33533/jrpps.v5i1.14075

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is a progressive chronic disease associated with high global morbidity and mortality. A pharmacoepidemiological approach is essential to understand risk determinants, comorbidities, patterns, and the rational use of medications in patient populations. A literature review was conducted on 11 observational studies comprising cohort, case-control, and cross-sectional designs. The included studies evaluated COPD risk factors, comorbidities, therapeutic effectiveness, and medication use patterns. COPD is influenced by multifactorial determinants including occupational exposure, smoking behavior, and metabolic conditions such as hyperlipidemia. Comorbidities including depression, malnutrition, and cardiovascular diseases contribute to increased exacerbation rates and mortality. Triple inhalation therapy (ICS/LAMA/LABA) reduced mortality compared with dual therapy. However, inappropriate antibiotic dosing and Drug-Related Problems (DRPs) were still identified. COPD is a complex chronic disease requiring a multidimensional approach through risk factor control, comorbidity management, and optimization of evidence-based pharmacotherapy within the framework of public health pharmacy.
Co-Authors Bawana Kheyza Dg Situru Nafeeza Shaqueenami Nasution Nisyah Mora Lestari Talitha Nur Dzakirah Wafa Nasution